Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/14850
Full metadata record
DC FieldValueLanguage
dc.contributor.authorvan der Tol, Arjan-
dc.contributor.authorVan Biesen, Wim-
dc.contributor.authorVan Laecke, Steven-
dc.contributor.authorBOGAERTS, Kris-
dc.contributor.authorDe Lombaert, Koen-
dc.contributor.authorWarrinnier, Hans-
dc.contributor.authorVanholder, Raymond-
dc.date.accessioned2013-03-27T13:30:21Z-
dc.date.available2013-03-27T13:30:21Z-
dc.date.issued2012-
dc.identifier.citationPLoS One, 7 (2), p. e31639-
dc.identifier.issn1932-6203-
dc.identifier.urihttp://hdl.handle.net/1942/14850-
dc.description.abstractMicroalbuminuria (MAU) is considered as a predictor or marker of cardiovascular and renal events. Statins are widely prescribed to reduce cardiovascular risk and to slow down progression of kidney disease. But statins may also generate tubular MAU. The current observational study evaluated the impact of statin use on the interpretation of MAU as a predictor or marker of cardiovascular or renal disease. Methodology/Principal Findings: We used cross-sectional data of ERICABEL, a cohort with 1,076 hypertensive patients. MAU was defined as albuminuria ≥20 mg/l. A propensity score was created to correct for “bias by indication” to receive a statin. As expected, subjects using statins vs. no statins had more cardiovascular risk factors, pointing to bias by indication. Statin users were more likely to have MAU (OR: 2.01, 95%CI: 1.34–3.01). The association between statin use and MAU remained significant after adjusting for the propensity to receive a statin based on cardiovascular risk factors (OR: 1.82, 95%CI: 1.14–2.91). Next to statin use, only diabetes (OR: 1.92, 95%CI: 1.00–3.66) and smoking (OR: 1.49, 95%CI: 0.99–2.26) were associated with MAU. Conclusions: Use of statins is independently associated with MAU, even after adjusting for bias by indication to receive a statin. In the hypothesis that this MAU is of tubular origin, statin use can result in incorrect labeling of subjects as having a predictor or marker of cardiovascular or renal risk. In addition, statin use affected the association of established cardiovascular risk factors with MAU, blurring the interpretation of multivariable analyses.-
dc.language.isoen-
dc.titleStatin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort study-
dc.typeJournal Contribution-
dc.identifier.epage6-
dc.identifier.issue2 (e31639)-
dc.identifier.spage1-
dc.identifier.volume7-
local.bibliographicCitation.jcatA1-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1371/journal.pone.0031639-
dc.identifier.isi000302796200080-
item.fulltextWith Fulltext-
item.contributorDe Lombaert, Koen-
item.contributorVan Biesen, Wim-
item.contributorVan Laecke, Steven-
item.contributorVanholder, Raymond-
item.contributorBOGAERTS, Kris-
item.contributorvan der Tol, Arjan-
item.contributorWarrinnier, Hans-
item.fullcitationvan der Tol, Arjan; Van Biesen, Wim; Van Laecke, Steven; BOGAERTS, Kris; De Lombaert, Koen; Warrinnier, Hans & Vanholder, Raymond (2012) Statin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort study. In: PLoS One, 7 (2), p. e31639.-
item.accessRightsOpen Access-
crisitem.journal.issn1932-6203-
crisitem.journal.eissn1932-6203-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
journal.pone.0031639.pdf112.31 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

14
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

12
checked on Jul 1, 2022

Page view(s)

56
checked on Jun 9, 2022

Download(s)

92
checked on Jun 9, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.